Global Biologics and Biosimilars Market Study 2015-2025, by Segment (Antibody, Hormone, Growth Factors), by Market (Tumor, DiabetesHormone, Cardiovascular), by Company (Roche, Amgen, AbbVie)
Snapshot
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
The global Biologics and Biosimilars market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
The global Biologics and Biosimilars market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
- Antibody
- Hormone
- Growth Factors
- Others
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Others
- Roche
- Amgen
- AbbVie
- Sanofi-Aventis
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- 3sbio
- Changchun High Tech
- CP Guojian
- Biotech
- Gelgen
- Innovent
- Dong Bao
- Ganlee
- United Laboratories
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
1 INDUSTRY OVERVIEW
1.1 Biologics and Biosimilars Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 BIOLOGICS AND BIOSIMILARS MARKET BY TYPE
2.1 By Type
2.1.1 Antibody
2.1.2 Hormone
2.1.3 Growth Factors
2.1.4 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 GLOBAL MARKET DEMAND
3.1 Segment Overview
3.1.1 Tumor
3.1.2 Diabetes
3.1.3 Cardiovascular
3.1.4 Hemophilia
3.1.5 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 MAJOR REGION MARKET
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 MAJOR COMPANIES LIST
5.1 Roche (Company Profile, Sales Data etc.)
5.2 Amgen (Company Profile, Sales Data etc.)
5.3 AbbVie (Company Profile, Sales Data etc.)
5.4 Sanofi-Aventis (Company Profile, Sales Data etc.)
5.5 Johnson & Johnson (Company Profile, Sales Data etc.)
5.6 Pfizer (Company Profile, Sales Data etc.)
5.7 Novo Nordisk (Company Profile, Sales Data etc.)
5.8 Eli Lilly (Company Profile, Sales Data etc.)
5.9 Novartis (Company Profile, Sales Data etc.)
5.10 Merck (Company Profile, Sales Data etc.)
5.11 3sbio (Company Profile, Sales Data etc.)
5.12 Changchun High Tech (Company Profile, Sales Data etc.)
5.13 CP Guojian (Company Profile, Sales Data etc.)
5.14 Biotech (Company Profile, Sales Data etc.)
5.15 Gelgen (Company Profile, Sales Data etc.)
5.16 Innovent (Company Profile, Sales Data etc.)
5.17 Dong Bao (Company Profile, Sales Data etc.)
5.18 Ganlee (Company Profile, Sales Data etc.)
5.19 United Laboratories (Company Profile, Sales Data etc.)
6 CONCLUSION
1.1 Biologics and Biosimilars Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 BIOLOGICS AND BIOSIMILARS MARKET BY TYPE
2.1 By Type
2.1.1 Antibody
2.1.2 Hormone
2.1.3 Growth Factors
2.1.4 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 GLOBAL MARKET DEMAND
3.1 Segment Overview
3.1.1 Tumor
3.1.2 Diabetes
3.1.3 Cardiovascular
3.1.4 Hemophilia
3.1.5 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 MAJOR REGION MARKET
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 MAJOR COMPANIES LIST
5.1 Roche (Company Profile, Sales Data etc.)
5.2 Amgen (Company Profile, Sales Data etc.)
5.3 AbbVie (Company Profile, Sales Data etc.)
5.4 Sanofi-Aventis (Company Profile, Sales Data etc.)
5.5 Johnson & Johnson (Company Profile, Sales Data etc.)
5.6 Pfizer (Company Profile, Sales Data etc.)
5.7 Novo Nordisk (Company Profile, Sales Data etc.)
5.8 Eli Lilly (Company Profile, Sales Data etc.)
5.9 Novartis (Company Profile, Sales Data etc.)
5.10 Merck (Company Profile, Sales Data etc.)
5.11 3sbio (Company Profile, Sales Data etc.)
5.12 Changchun High Tech (Company Profile, Sales Data etc.)
5.13 CP Guojian (Company Profile, Sales Data etc.)
5.14 Biotech (Company Profile, Sales Data etc.)
5.15 Gelgen (Company Profile, Sales Data etc.)
5.16 Innovent (Company Profile, Sales Data etc.)
5.17 Dong Bao (Company Profile, Sales Data etc.)
5.18 Ganlee (Company Profile, Sales Data etc.)
5.19 United Laboratories (Company Profile, Sales Data etc.)
6 CONCLUSION
LIST OF TABLES
Table Global Biologics and Biosimilars Market 2015-2018, by Type, in USD Million
Table Global Biologics and Biosimilars Market Forecast 2019-2025, by Type, in USD Million
Table Roche Overview List
Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Cost, Gross Margin)
Table Amgen Overview List
Table Biologics and Biosimilars Business Operation of Amgen (Sales Revenue, Cost, Gross Margin)
Table AbbVie Overview List
Table Biologics and Biosimilars Business Operation of AbbVie (Sales Revenue, Cost, Gross Margin)
Table Sanofi-Aventis Overview List
Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Sales Revenue, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Biologics and Biosimilars Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)
Table Pfizer Overview List
Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Biologics and Biosimilars Business Operation of Novo Nordisk (Sales Revenue, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Biologics and Biosimilars Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin)
Table Novartis Overview List
Table Biologics and Biosimilars Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
Table Merck Overview List
Table Biologics and Biosimilars Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
Table 3sbio Overview List
Table Biologics and Biosimilars Business Operation of 3sbio (Sales Revenue, Cost, Gross Margin)
Table Changchun High Tech Overview List
Table Biologics and Biosimilars Business Operation of Changchun High Tech (Sales Revenue, Cost, Gross Margin)
Table CP Guojian Overview List
Table Biologics and Biosimilars Business Operation of CP Guojian (Sales Revenue, Cost, Gross Margin)
Table Biotech Overview List
Table Biologics and Biosimilars Business Operation of Biotech (Sales Revenue, Cost, Gross Margin)
Table Gelgen Overview List
Table Biologics and Biosimilars Business Operation of Gelgen (Sales Revenue, Cost, Gross Margin)
Table Innovent Overview List
Table Biologics and Biosimilars Business Operation of Innovent (Sales Revenue, Cost, Gross Margin)
Table Dong Bao Overview List
Table Biologics and Biosimilars Business Operation of Dong Bao (Sales Revenue, Cost, Gross Margin)
Table Ganlee Overview List
Table Biologics and Biosimilars Business Operation of Ganlee (Sales Revenue, Cost, Gross Margin)
Table United Laboratories Overview List
Table Biologics and Biosimilars Business Operation of United Laboratories (Sales Revenue, Cost, Gross Margin)
Table Global Biologics and Biosimilars Market 2015-2018, by Type, in USD Million
Table Global Biologics and Biosimilars Market Forecast 2019-2025, by Type, in USD Million
Table Roche Overview List
Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Cost, Gross Margin)
Table Amgen Overview List
Table Biologics and Biosimilars Business Operation of Amgen (Sales Revenue, Cost, Gross Margin)
Table AbbVie Overview List
Table Biologics and Biosimilars Business Operation of AbbVie (Sales Revenue, Cost, Gross Margin)
Table Sanofi-Aventis Overview List
Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Sales Revenue, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Biologics and Biosimilars Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)
Table Pfizer Overview List
Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Biologics and Biosimilars Business Operation of Novo Nordisk (Sales Revenue, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Biologics and Biosimilars Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin)
Table Novartis Overview List
Table Biologics and Biosimilars Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
Table Merck Overview List
Table Biologics and Biosimilars Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
Table 3sbio Overview List
Table Biologics and Biosimilars Business Operation of 3sbio (Sales Revenue, Cost, Gross Margin)
Table Changchun High Tech Overview List
Table Biologics and Biosimilars Business Operation of Changchun High Tech (Sales Revenue, Cost, Gross Margin)
Table CP Guojian Overview List
Table Biologics and Biosimilars Business Operation of CP Guojian (Sales Revenue, Cost, Gross Margin)
Table Biotech Overview List
Table Biologics and Biosimilars Business Operation of Biotech (Sales Revenue, Cost, Gross Margin)
Table Gelgen Overview List
Table Biologics and Biosimilars Business Operation of Gelgen (Sales Revenue, Cost, Gross Margin)
Table Innovent Overview List
Table Biologics and Biosimilars Business Operation of Innovent (Sales Revenue, Cost, Gross Margin)
Table Dong Bao Overview List
Table Biologics and Biosimilars Business Operation of Dong Bao (Sales Revenue, Cost, Gross Margin)
Table Ganlee Overview List
Table Biologics and Biosimilars Business Operation of Ganlee (Sales Revenue, Cost, Gross Margin)
Table United Laboratories Overview List
Table Biologics and Biosimilars Business Operation of United Laboratories (Sales Revenue, Cost, Gross Margin)
LIST OF FIGURES
Figure Global Biologics and Biosimilars Market Growth 2015-2018, by Type, in USD Million
Figure Global Biologics and Biosimilars Market Growth 2015-2018, by Type, in USD Million
